Skip to main content Accessibility help
×
Home

An alternative approach to mixed hearing loss in otosclerosis: stapes surgery combined with an active middle-ear implant

  • H R F Powell (a1), I Pai (a1), H Ghulam (a1) and D Jiang (a1)

Abstract

Objective:

To report a novel management strategy for mixed hearing loss in advanced otosclerosis.

Methods:

A 50-year-old male was referred to St Thomas’ Hearing Implant Centre with otosclerosis; he was no longer able to wear conventional hearing aids because of recurrent otitis externa. The patient underwent short process incus vibroplasty (using the Med-El Vibrant Soundbridge device), followed at a suitable interval (six weeks) by stapes surgery. The main outcome measures were: pure tone audiometry, functional gain and monosyllabic word recognition scores.

Results:

Post-operative pure tone audiometry showed a reduction of the mean air–bone gap from 55 dB HL to 20 dB HL. The residual mixed hearing loss was rehabilitated with the Vibrant Soundbridge, with an average device gain of 32 dB. The monosyllabic word recognition scores in quiet at 65 dB improved from 37 to 100 per cent when using the Vibrant Soundbridge at six months after switch-on of the device.

Conclusion:

Stapedotomy in conjunction with incus short process vibroplasty (i.e. inner-ear vibroplasty) is a safe and promising procedure for managing advanced otosclerosis with mixed hearing loss in selected patients.

Copyright

Corresponding author

Address for correspondence: Prof Dan Jiang, Hearing Implant Centre, 2nd floor Lambeth Wing, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UK E-mail: dan.jiang@kcl.ac.uk

Footnotes

Hide All

Presented at the 6th International Congress on Bone Conduction Hearing and Related Technologies, 17−20 May 2017, Nijmegen, the Netherlands.

Footnotes

References

Hide All
1Hentschel, MA, Huizinga, P, van der Velden, DL, Wegner, L, Bittermann, AJ, Vander Heijden, GJ et al. Limited evidence of the effect of sodium fluoride on deterioration of hearing loss in patients with otosclerosis: a systematic review of the literature. Otol Neurotol 2014;35:1052–7.
2Burrell, SP, Cooper, HC, Proops, DW. The bone anchored hearing aid-the third option for otosclerosis. J Laryngol Otol 1996;21:31–7.
3Quaranta, N, Bartoli, R, Lopriore, A, Fernandez-Vega, S, Giagnotti, F, Quaranta, A. Cochlear implantation in otosclerosis. Otol Neurotol 2005;26:983–7.
4Schmuziger, N, Schimmann, F, Wengen, D, Patscheke, J, Probst, R. Long-term assessment after implantation of the Vibrant Soundbridge device. Otol Neurotol 2006;27:183–8.
5Mosnier, I, Sterkers, O, Boucarra, D, Labassi, S, Bebear, JP, Bordure, P et al. Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years. Ear Hear 2008;29:281–4.
6Schraven, SP, Dalhoff, E, Wildenstein, D, Hagen, R, Gummer, AW, Mlynski, R. Alternative fixation of an active middle ear implant at the short incus process. Audiol Neurotol 2014;19:111.
7Mlynski, R, Dalhoff, E, Heyd, A, Wildenstein, D, Rak, K, Radeloff, A et al. Standardized active middle-ear implant coupling to the short incus process. Otol Neurotol 2015;36:1390–8.
8Dumon, T. Vibrant Soundbridge middle ear implant in otosclerosis: technique - indication. Adv Otorhinolaryngol 2007;65:320–2.
9Kontorinis, G, Lenarz, T, Mojallal, H, Hinze, AL, Schwab, B. Power stapes: an alternative method for treating hearing loss in osteogenesis imperfecta? Otol Neurotol 2011;32:589–95.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed